Issue of Fee Shares

MedPal AI Plc (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, announces that it has issued 3,600,000 new ordinary shares ("Fee Shares") in lieu of £90,000 of cash in respect of advisory fees incurred by the Company. The Fee Shares have been valued at 2.5p per share, equivalent to the price per share issued pursuant to the placing announced by the Company on 17 April 2026.

The Fee Shares will, when issued, rank pari passu in all respects with the existing ordinary shares of the Company, including the right to receive all dividends and other distributions declared, made or paid after their date of issue.

Application will be made to the London Stock Exchange for the Fee Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the Fee Shares will commence at 8.00 a.m. on 24 April 2026.

Following Admission, the Company's issued ordinary share capital will consist of 616,041,036 ordinary shares of £0.0002 each, with one voting right per share. No ordinary shares will be held in treasury. The total number of voting rights in the Company following Admission will therefore be 616,041,036, which figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Directors of the Company are responsible for the contents of this announcement.